Shizuoka, Japan

Akira Yagi

This inventor holds 1 USPTO granted patent. Top assignee: Toyo Jozo Kabushiki Kaisha. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Yagi. Retrieved from https://idiyas.com/inventor/akira-yagi-6tamq85v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akira Yagi: Innovator in Antibiotic Development

Introduction

Akira Yagi is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of antibiotics, particularly through his work on a family of antibiotics known as aculeacins. His innovative research has the potential to impact the treatment of infections caused by pathogenic yeasts and fungi.

Latest Patents

Yagi holds a patent for Antibiotic aculeacins, which includes aculeacin-A, -B, -C, -D, -E, -F, and -G. These antibiotics are produced from the cultured broth of Aspergillus aculeatus FERM-P 2324. This patent represents a significant advancement in the development of effective treatments against various fungal infections.

Career Highlights

Akira Yagi is associated with Toyo Jozo Co., Ltd., where he has been instrumental in advancing antibiotic research. His work has garnered attention for its innovative approach to combating pathogenic organisms. With 1 patent to his name, Yagi continues to contribute to the scientific community.

Collaborations

Yagi has collaborated with notable colleagues, including Kimio Mizuno and Minoru Toriya. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of antibiotics.

Conclusion

Akira Yagi's contributions to antibiotic development highlight the importance of innovation in addressing health challenges. His work on aculeacins showcases the potential for new treatments against fungal infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…